2016 Clinical Tuberculosis Symposium: an Update on Treatment and Prevention
Wednesday, March 30th, 2016- 8:00am-4:30pm CT
Student Life Center, Vanderbilt University, 310 25th Ave South, Nashville TN 37240
Commodore Ballroom A
Approved for 6.75 CME Credits
The Vanderbilt Tuberculosis Center (VTC) and the Tuberculosis Elimination Program of Tennessee Department of Health (TDH), in collaboration with the Southeastern National Tuberculosis Center (SNTC), are pleased to announce the “2016 Clinical Tuberculosis Symposium: An Update on Treatment and Prevention.” This event will engage participants through presentations of TB cases in Tennessee, analysis of clinical challenges and opportunities by a panel of clinical and laboratory experts, lectures and participant discussions. Registration and information about continuing medical education (CME) credits will follow in the coming months.
Target Audience: Physicians, advanced practice nurses, clinical researchers, and other healthcare professionals involved in the diagnosis and management of TB disease and M. tuberculosis infection.
- Presentation of interesting and instructive TB cases, including those with co-morbidities, unique risk factors, diagnostic and/or clinical management challenges
- Lectures on multidrug-resistant TB, TB and diabetes mellitus, HIV-related TB, and the use of the once-weekly isoniazid/rifapentine (“3HP”) regimen for treatment of M. tuberculosis infection
- Expert analysis and panel discussions of clinical issues
- Participant engagement and discussion
Registration is free and lunch will be provided.
For more information contact Hilary Vansell, Program Coordinator, Vanderbilt TB Center
#1: Taking Aim on TB Elimination- How Are We Doing?
#2: Epidemiology, Treatment and Prevention of MDR-TB
#4: Challenges in the Management of Pan-sensitive TB
#5: Diabetes and TB- The Global Synergy of Two Pandemics
#6: Case 4 / TB, Diabetes, Relapse and Recovery
#7: Case 5 / TB and HIV Co-infection, Research Update
#8: Update on the Treatment of Latent TB Infection
#9: Case 6 / 3HP and Flu Syndrome- What is the Underlying Mechanism?